查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1772265

Tremfya 市场规模、份额、趋势分析报告：按应用程式、分销管道、地区、细分市场预测，2025 年至 2033 年

Tremfya Market Size, Share & Trends Analysis Report By Application (Plaque Psoriasis, Psoriatic Arthritis (PsA)), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

Tremfya市场摘要

2024 年全球 Tremfya 市场规模估计为 36.7 亿美元，预计到 2033 年将达到 72.9 亿美元，2025 年至 2033 年的复合年增长率为 7.60%。慢性寻常性干癣和银屑病关节炎盛行率的不断上升推动了对先进生物製药的需求。

这些自体免疫疾病的发生率在全球范围内持续上升，导致对有效长期治疗方案的需求日益增长。 Tremfya 是一种针对白细胞介素23 (IL-23) 的单株抗体，已在中度至重度病例中显示出强大的疗效和持久的效果。其稳定的临床疗效和良好的安全性已获得皮肤科医生和风湿症医师的认可。

杨森製药强大的市场策略和竞争定位推动着 Tremfya 的商业性成功。与包括 TNF 抑制剂和 IL-17 抑制剂在内的几种现有生物製药相比，该药物的差异化之处在于其优异的疗效数据。头对头试验证明了 Tremfya 能够快速清除皮肤病灶并实现持续缓解，这使其在治疗领域具有战略优势。例如，2024 年 10 月，强生公司的 SPECTREM 试验显示，Tremfya 有效清除了头皮、脸部、手、脚和生殖器等棘手的牛皮癣部位，清除率高达 80%。大多数患者在 48 週内保持皮肤清洁或几乎清洁。该治疗还减轻了瘙痒和疼痛等症状，显着改善了患者的生活品质。

持续的临床研究和生命週期管理工作为 Tremfya 市场的未来成长提供支援。新的临床试验正在探索化脓性汗腺炎和克隆氏症更多适应症，这可能会显着拓宽治疗范围。该药物的製造商也正在投资真实世界临床试验，以检验其在不同族群中的疗效。人们对精准医疗和生物标记主导疗法的兴趣日益浓厚，增强了 IL-23 抑制剂在个人化治疗方法中的相关性。与专科药房的合作以及精简的分销网络提高了该药物在高需求市场的可得性。此外，持续关注医生教育和患者援助计划也增强了品牌忠诚度。

目录

第一章调查方法与范围

第二章执行摘要

第三章 Tremfya 市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章 Tremfaya 市场：应用程式业务分析

  • 2024 年和 2033 年应用市场占有率
  • 应用程式细分仪表板
  • 按应用分類的市场规模、预测和趋势分析（2021-2033 年）
  • 斑块型干癣
  • 干癣性关节炎（PsA）
  • 其他的

第五章 Tremfya 市场：通路业务分析

  • 2024年及2033年分销通路市场占有率
  • 分销通路细分仪表板
  • 按分销管道分類的市场规模、预测和趋势分析（2021-2033 年）
  • 医院药房
  • 零售药局
  • 网路药局

第六章 Tremfya 市场：区域估计与趋势分析

  • 2024 年及 2033 年区域市场占有率分析
  • 区域市场仪表板
  • 2021-2033年市场规模与预测趋势分析：
  • 北美洲
    • 按国家/地区，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Johnson &Johnson Services, Inc.
Product Code: GVR-4-68040-648-6

Tremfya Market Summary

The global tremfya market size was estimated at USD 3.67 billion in 2024 and is projected to reach USD 7.29 billion by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greater demand for advanced biologic therapies.

These autoimmune conditions continue to rise globally, resulting in a growing need for effective and long-term treatment options. Tremfya, a monoclonal antibody that targets interleukin-23 (IL-23), has delivered strong efficacy and durable outcomes in moderate-to-severe cases. Its consistent clinical performance and favorable safety profile have strengthened its acceptance among dermatologists and rheumatologists.

Janssen Pharmaceuticals ' strong marketing strategies and competitive positioning drive Tremfya's commercial success. The drug has differentiated itself through superior efficacy data compared to some existing biologics, including TNF and IL-17 inhibitors. Head-to-head studies have shown Tremfya's ability to achieve rapid skin clearance and sustained response, giving it a strategic advantage in the treatment landscape. For instance, In October 2024, Johnson & Johnson's SPECTREM study showed Tremfya effectively cleared difficult psoriasis areas like the scalp, face, hands, feet, and genitals, with clearance rates up to 80%. Most patients maintained clear or almost clear skin through week 48. The treatment also significantly improved patients' quality of life by reducing symptoms like itch and pain.

Ongoing clinical research and lifecycle management initiatives support the Tremfya market's future growth. New clinical trials are exploring expanded applications, such as hidradenitis suppurativa and Crohn's disease, which could significantly widen its therapeutic scope. The drug's manufacturer also invests in real-world evidence studies to validate its effectiveness in diverse populations. The growing interest in precision medicine and biomarker-driven therapies is increasing the relevance of IL-23 inhibitors in personalized treatment regimens. Partnerships with specialty pharmacies and streamlined distribution networks enhance availability in high-demand markets. The company's continued focus on physician education and patient support programs reinforces brand loyalty.

Global Tremfya Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global Tremfya market report based on application, distribution channel and region:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Plaque Psoriasis
  • Psoriatic Arthritis (PsA)
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tremfya Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Tremfya Market: Application Business Analysis

  • 4.1. Application Market Share, 2024 & 2033
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Plaque Psoriasis
    • 4.4.1. Plaque Psoriasis Market, 2021 - 2033 (USD Million)
  • 4.5. Psoriatic Arthritis (PsA)
    • 4.5.1. Psoriatic Arthritis (PsA) Market, 2021 - 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Tremfya Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2033
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
  • 5.6. Online Pharmacies
    • 5.6.1. Online Pharmacies Market, 2021 - 2033 (USD Million)

Chapter 6. Tremfya Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Tremfya Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Tremfya Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Johnson & Johnson Services, Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Application Benchmarking
      • 7.5.1.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Tremfya market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 North America Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 8 North America Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9 U.S. Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 Canada Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 12 Canada Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 13 Mexico Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Europe Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 16 Europe Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 17 Europe Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 UK Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 19 UK Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 20 Germany Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 France Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 23 France Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 24 Italy Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 25 Italy Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 Spain Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 27 Spain Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 28 Norway Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 29 Norway Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Denmark Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 31 Denmark Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Sweden Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 33 Sweden Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 37 Japan Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 38 Japan Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 39 China Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 40 China Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 India Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 42 India Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 43 Australia Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 44 Australia Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 45 South Korea Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 46 South Korea Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47 Thailand Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 48 Thailand Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 49 Latin America Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 50 Latin America Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 51 Latin America Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 52 Brazil Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 53 Brazil Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 Argentina Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 55 Argentina Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 56 Middle East & Africa Tremfya market, by country, 2021 - 2033 (USD Million)
  • Table 57 Middle East & Africa Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 58 Middle East & Africa Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 59 South Africa Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 60 South Africa Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 61 Saudi Arabia Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 62 Saudi Arabia Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 UAE Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 64 UAE Tremfya market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 65 Kuwait Tremfya market, by application, 2021 - 2033 (USD Million)
  • Table 66 Kuwait Tremfya market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Tremfya market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Tremfya market dynamics
  • Fig. 12 Tremfya market: Porter's five forces analysis
  • Fig. 13 Tremfya market: PESTLE analysis
  • Fig. 14 Application market, 2021 - 2033 (USD Million)
  • Fig. 15 Plaque Psoriasis market, 2021 - 2033 (USD Million)
  • Fig. 16 Psoriatic Arthritis (PsA) market, 2021 - 2033 (USD Million)
  • Fig. 17 Others market, 2021 - 2033 (USD Million)
  • Fig. 18 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 19 Hospital Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 20 Retail Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 21 Online Pharmacies market, 2021 - 2033 (USD Million)
  • Fig. 22 Tremfya market revenue, by region
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. country dynamics
  • Fig. 26 U.S. Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 27 Canada country dynamics
  • Fig. 28 Canada Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 29 Mexico country dynamics
  • Fig. 30 Mexico Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 31 Europe Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 32 UK country dynamics
  • Fig. 33 UK Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 34 Germany country dynamics
  • Fig. 35 Germany Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 36 France country dynamics
  • Fig. 37 France Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 38 Italy country dynamics
  • Fig. 39 Italy Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 40 Spain country dynamics
  • Fig. 41 Spain Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 42 Norway country dynamics
  • Fig. 43 Norway Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 44 Sweden country dynamics
  • Fig. 45 Sweden Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 46 Denmark country dynamics
  • Fig. 47 Denmark Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 48 Asia Pacific Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 49 Japan country dynamics
  • Fig. 50 Japan Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 51 China country dynamics
  • Fig. 52 China Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 53 India country dynamics
  • Fig. 54 India Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia country dynamics
  • Fig. 56 Australia Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea country dynamics
  • Fig. 58 South Korea Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 59 Thailand country dynamics
  • Fig. 60 Thailand Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil country dynamics
  • Fig. 63 Brazil Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 64 Argentina country dynamics
  • Fig. 65 Argentina Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 66 MEA Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 67 South Africa country dynamics
  • Fig. 68 South Africa Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 69 Saudi Arabia country dynamics
  • Fig. 70 Saudi Arabia Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 71 UAE country dynamics
  • Fig. 72 UAE Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 73 Kuwait country dynamics
  • Fig. 74 Kuwait Tremfya market, 2021 - 2033 (USD Million)
  • Fig. 75 Company categorization
  • Fig. 76 Company market position analysis
  • Fig. 77 Strategic framework